CALR and cancer: It has been unfolded that ferroptosis of the cancer cell is able to promote the release of high mobility group box 1 (HMGB1) and the expression of calreticulin (CRT), two typical damage-associated molecular patterns (DAMPs), from these dying cells, and thereby elicit a series of pro-inflammatory antitumor immune responses37–39.